The aim of this study was to determine whether there exists a higher prevalence of tinnitus in patients with temporomandibular disorders (TMDs) than in patients without TMDs. A systematic review was conducted in PubMed/MEDLINE for articles published between January 1992 and April 2018 in accordance with the PRISMA statement. Studies were included in this review only if they assessed TMDs using the research diagnostic criteria (RDC)/TMD or DC/TMD. A total of five studies were included in the systematic review, and a random-effects meta-analysis of three of the studies was conducted. In all of the selected studies, the prevalence of tinnitus was higher in patients with TMDs (35.8% to 60.7%) than in patients without TMDs (9.7% to 26.0%). The odds ratio of suffering from tinnitus among patients with TMDs was 4.45 (95% CI 1.64-12.11. P = 0.003). Thus, despite the limitations of the included studies, this review demonstrates that the prevalence of tinnitus in TMD patients is significantly higher than that in patients without TMD.

The purpose of this prospective case control study is to describe in growing patients with mandibular hypoplasia, treatment outcomes following functional therapy in terms of volumetric changes in nasopharynx and oropharynx, that is, upper and lower pharynx. We recruited 60 study participants aged between 8 and 12 years having mandibular Class II malocclusion and a reduced upper airway (UA) size, as determined by McNamara cephalometric analyses. Forty patients received Twin Block treatment, whereas the remaining 20 patients did not receive treatment, thus constituting the control group. The control group included patients who did not start treatment after their first visit but returned for a consultation one or 2 years later. All patients underwent an initial teleradiography examination of the skull and a final teleradiography examination to measure changes using McNamara cephalometric analysis of the UA. Pretreatment and posttreatment changes were assessed using Student's t test for independent samples with a significance level of 0.05. Both anatomical structures analyzed—the upper pharynx (nasopharynx) and lower pharynx (oropharynx)—showed significant increases after treatment regardless of whether the patients were boys or girls. The controls showed a decrease in UA size on average after approximately 2 years of growth. A clear relationship exists between the mandibular advancement achieved with TB treatment and an increased UA size. Therefore, the appliance is considered suitable for improving the respiratory quality of growing patients with a decreased UA size.

The facemask is a widely used device in the treatment of Class III malocclusion and is intended to anteriorly displace the superior maxilla or stimulate its growth in that direction. The main goal of this study was to evaluate the effects of treatment using orthopedic maxillary expansion with facemask therapy in patients with Class III malocclusion. Sixty‐four patients, with a mean age of 8.14 ± 1.18 years at the start of treatment and a mean age of 9.78 ± 1.19 years at the end, were treated using orthopedic maxillary expansion and associated facemask therapy. The patients were evaluated using lateral head teleradiography before and after treatment, and the differences were analyzed. In addition, binary logistic regression was used as a model for predicting successful treatment. When comparing the changes achieved by treatment, statistically significant favorable changes were found at the skeletal level. Furthermore, an improvement in the airways at all levels was detected. Orthopedic maxillary expansion associated with facemask therapy has proven effective in treating early skeletal Class III malocclusion.

Local delivery of OPG-Fc or zoledronate inhibits bone resorption and therefore tooth movement. OPG-Fc was more effective than zoledronate in blocking the action of osteoclasts.

No abstract